Acerus Pharmaceuticals (OTCMKTS:TRLPF) Reaches New 52-Week High at $2.21

Acerus Pharmaceuticals Co. (OTCMKTS:TRLPFGet Rating)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $2.21 and last traded at $2.21, with a volume of 100 shares changing hands. The stock had previously closed at $2.21.

The stock’s 50 day moving average price is $2.61 and its 200-day moving average price is $0.93. The company has a quick ratio of 0.90, a current ratio of 1.35 and a debt-to-equity ratio of 0.64.

About Acerus Pharmaceuticals (OTCMKTS:TRLPF)

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.

Further Reading

Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.